Keyphrases
Progesterone Receptor
100%
Receptor Binding
100%
Human Myometrium
100%
Term-pregnant
100%
Chromatin Immunoprecipitation (ChIP)
50%
Myometrium
50%
Progesterone
50%
Myometrial
50%
Active Labor
50%
RNA Sequencing (RNA-seq)
33%
CBX7
33%
TNS1
33%
ATP11A
33%
Gene Expression
16%
Binding Analysis
16%
Histone Modification
16%
Uterus
16%
Mechanistic Studies
16%
Therapeutic Target
16%
In Vitro Study
16%
Response Element
16%
Multiple Pathways
16%
Differential Binding
16%
Functional Analysis
16%
Promoter Region
16%
Receptor Targets
16%
Transcriptional Activation
16%
Steroid Hormones
16%
MRNA Level
16%
Genome-wide Analysis
16%
Intergenic Region
16%
Smooth muscle Tissue
16%
Myometrial Smooth muscle
16%
Human Myometrial Tissue
16%
Contractile Phenotype
16%
Active Histone Marks
16%
Labor Stage
16%
Medicine and Dentistry
Receptor Binding
100%
Myometrium
100%
Progesterone Receptor
100%
Chromatin Immunoprecipitation
50%
Progesterone
50%
RNA Sequence
33%
Promoter Region
16%
Gene Expression
16%
In Vitro
16%
Transcription Initiation
16%
DNA Responsive Element
16%
Histone
16%
Smooth Muscle
16%
Genome Wide Association Study
16%
Transactivation
16%
Messenger RNA
16%
Histone Modification
16%
Steroid Hormone
16%
Immunology and Microbiology
Receptor Binding
100%
Myometrium
100%
Chromatin Immunoprecipitation
75%
RNA Sequence
50%
Smooth Muscle
25%
Gene Expression
25%
DNA Responsive Element
25%
Promoter Region
25%
Transcription Initiation
25%
Muscle Tissue
25%
Transactivation
25%
Histone Modification
25%
Histone
25%
Biochemistry, Genetics and Molecular Biology
Progesterone Receptor
100%
Receptor Binding
100%
Chromatin Immunoprecipitation
50%
Progesterone
50%
RNA Sequence
33%
Transactivation
16%
Histone Modification
16%
In Vitro Study
16%
Genome Wide Association Study
16%
Gene Expression
16%
Response Element
16%
Transcription Initiation
16%
Cyclic Adenosine Monophosphate
16%
Pribnow Box
16%
Messenger RNA
16%
Histone
16%